Frédéric Braccini
01.06.2013
News
24.05.2016
Almirall and Bicosome enter into a collaboration and sublicense agreement for the development of topical drug delivery formulations
Almirall S.A., the global pharmaceutical company based in Barcelona, and Bicosome, a start-up company that develops and commercializes high performance cosmetic and dermopharmaceutical ingredients, announced that they have entered into […]
14.03.2016
Merck Initiates Phase III Study of MSB11022
Merck, a leading science and technology company, today announced the initiation of a global Phase III clinical study of MSB11022, a proposed biosimilar of adalimumab, in chronic plaque psoriasis. This […]
15.06.2017
Syneron Candela’s PicoWay picosecond laser now with three wavelengths and resolve fractional
PicoWay® picosecond laser received U.S. Food and Drug Administration (FDA) clearance for a new ultra-short 785 nm wavelength, making it the third FDA cleared wavelength for PicoWay. The new ultra-short […]